financetom
Business
financetom
/
Business
/
Medical Device Components LLC and Lighteum LLC Unveil New Brand Identity, Uniting Precision and Innovation as Lighteum Medical
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Medical Device Components LLC and Lighteum LLC Unveil New Brand Identity, Uniting Precision and Innovation as Lighteum Medical
Oct 6, 2025 8:34 AM

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Medical Device Components LLC (MDC) today announced its official rebranding as Lighteum Medical, following the divestment from Johnson Matthey as a stand-alone company and the successful acquisition of Lighteum LLC. This strategic evolution positions Lighteum Medical as a preeminent leader in precision components made from precious metals and nitinol materials, empowering MedTech advancements worldwide.

The unified brand, Lighteum Medical, reflects the seamless integration of MDC's proven expertise in high-volume manufacturing of precious metal micromachined components and nitinol tubes and sheet with Lighteum LLC's focus on rapid development and delivery of nitinol-based complex components. Known for their radiopacity, electrical conductivity, and superelastic properties, these unique metals enable transformative applications in minimally invasive medical devices for electrophysiology, vascular intervention, and neurovascular therapies. The new identity underscores a commitment to rapid customer response, cutting-edge technology, and technical prowess in fabricating highly complex medical components.

Lighteum Medical's product portfolio includes platinum group metal (PGM) alloys, custom-engineered PGM components, nitinol sheets and tubes, as well as high-complexity nitinol components processed through advanced techniques like femtosecond laser cutting, shape-setting, and electropolishing. These offerings support minimally invasive medical devices used in high-growth clinical specialties, helping to improve patient outcomes around the world.

"Our rebrand to Lighteum Medical marks an exciting new chapter, combining the strengths of two innovative entities to deliver unparalleled value to our customers," said Don Freeman, CEO of Lighteum Medical. "By merging MDC's precision durability with Lighteum's innovative speed, we are forging a powerhouse dedicated to setting new standards in complex medical manufacturing. The name Lighteum Medical embodies our continued evolution as a high-growth, innovation-driven partner for the world's leading MedTech companies."

The company operates four state-of-the-art manufacturing and technology centers globally, with headquarters and micromachining operations in San Diego, CA; a Rapid Development Center in Oceanside, CA; a Nitinol Center of Excellence in Mexicali, Mexico; and Asia-Pacific platinum operations in Australia. Lighteum Medical remains committed to regulatory compliance, including ISO certifications, and continues to prioritize continuity of supply to its customers worldwide.

Lighteum Medical invites customers, partners, and industry leaders to explore the new brand at www.lighteum.com.

For further information, please contact:

Lighteum Medical Media Relations

Email: [email protected]

About Lighteum Medical

Lighteum Medical is a global leader in the development and manufacture of precision medical components, uniting the legacies of Medical Device Components LLC (MDC) and Lighteum LLC to specialize in platinum group metals and high-complexity nitinol-based solutions. With decades of expertise in metallurgy, micromachining, femtosecond laser processing, shape-setting, and electropolishing technologies, Lighteum Medical serves the world's leading medical device companies, transforming customer experiences through transparency, speed, and cutting-edge manufacturing technologies. Visit www.lighteum.com for more information.

View original content to download multimedia:https://www.prnewswire.com/news-releases/medical-device-components-llc-and-lighteum-llc-unveil-new-brand-identity-uniting-precision-and-innovation-as-lighteum-medical-302574841.html

SOURCE Lighteum Medical

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US airline flight cancellations fall as air traffic absences shrink
US airline flight cancellations fall as air traffic absences shrink
Nov 12, 2025
WASHINGTON, Nov 12 (Reuters) - U.S. flight cancellations have fallen sharply over the last day as air traffic control absences have shrunk just hours before the House of Representatives is set to vote on a bill Wednesday to end a record-setting government shutdown. Airlines in the United States have canceled nearly 900 flights Wednesday -- the lowest in six days...
SchoolWise Partners Advises in the Sale of 6-Unit Child Care Portfolio in Texas
SchoolWise Partners Advises in the Sale of 6-Unit Child Care Portfolio in Texas
Nov 12, 2025
MIAMI, Nov. 12, 2025 /PRNewswire/ -- SchoolWise Partners (SchoolWise), the nation's leading sell-side advisor to owners of early childhood education, is pleased to announce the closing of Kids' Zone Learning Center (Kids' Zone), a portfolio of six (6) private schools located in and around Austin, Texas. SchoolWise Partners acted as the exclusive sell-side advisor to the Seller of Kids' Zone....
Form 8.3
Form 8.3
Nov 12, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Nov 12, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if...
Copyright 2023-2026 - www.financetom.com All Rights Reserved